Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001443590 | SCV001646567 | likely benign | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001443590 | SCV002797801 | likely benign | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-08-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279181 | SCV001466263 | uncertain significance | Methylcrotonyl-CoA carboxylase deficiency | 2020-08-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003938595 | SCV004750559 | likely benign | MCCC2-related disorder | 2019-07-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |